Paradigm Biocapital Advisors LP Spdr Ser Tr Spdr S&P Biotech E Transaction History

Paradigm Biocapital Advisors LP

$3.1 Billion
Q3 2025

A detailed history of Paradigm Biocapital Advisors LP transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 1,000,000 shares of XBI stock, worth $114 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares

1,000,000

Holding current value

$114 Million

% of portfolio

3.23%

0 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form

No transaction found.

Others Institutions Holding XBI

# of Institutions

857

Shares Held

121M

Call Options Held

28.4M

Put Options Held

34.2M

Goldman Sachs Group Inc New York, NY

22.7M
Shares

$2.59 Billion
0.29% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13.8M
Shares

$1.58 Billion
2.64% of portfolio
Jpmorgan Chase & CO New York, NY

13.5M
Shares

$1.54 Billion
0.09% of portfolio
Citigroup Inc

10.9M
Shares

$1.24 Billion
0.5% of portfolio
Morgan Stanley New York, NY

10.6M
Shares

$1.21 Billion
0.07% of portfolio

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Account

Paradigm Biocapital Advisors LP Spdr Ser Tr Spdr S&P Biotech E Transaction History